Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Takanobu Kan"'
Autor:
Shinichi Ashizawa, Takanobu Kan, Shunsuke Takahagi, Mikio Kawai, Sayuri Toda, Yasumasa Iwasaki, Shuhei Karakawa, Michihiro Hide, Akio Tanaka
Publikováno v:
Journal of Plastic and Reconstructive Surgery, Vol 3, Iss 2, Pp 94-98 (2024)
Objectives: The majority of infantile hemangiomas shrink on their own, but when there is a chance of functional impairment, ulceration, or aesthetic issues, an active therapeutic intervention is needed. Propranolol is effective in treating infantile
Externí odkaz:
https://doaj.org/article/e5b1b17c1e694ecf982c6e409d631e97
Autor:
Hayato Mizuno, MD, Shunsuke Takahagi, MD, PhD, Daiki Matsubara, MD, PhD, Takanobu Kan, MD, PhD, Keiichi Mori, MD, Koji Arihiro, MD, PhD, Akio Tanaka, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 34, Iss , Pp 32-35 (2023)
Externí odkaz:
https://doaj.org/article/42f80663ff4c4eefa0372262a081996e
Autor:
Takanobu Kan, Shunsuke Takahagi, Daiki Matsubara, Emi Murakami, Mikio Kawai, Michihiro Hide, Akio Tanaka
Publikováno v:
Regenerative Therapy, Vol 19, Iss , Pp 154-157 (2022)
Cultured epidermal autografts (CEAs) are used to treat extensive burns, giant congenital melanocytic nevi, and epidermolysis bullosa, but information about the long-term clinical course after CEA transplantation is scarce. Here we report 10 years’
Externí odkaz:
https://doaj.org/article/62dd2108de6d4cb5af1a7e4cdf813ace
Autor:
Tomofumi Numata, Shunsuke Takahagi, Kaori Ishii, Satoshi Morioke, Takanobu Kan, Hayato Mizuno, Yuhki Yanase, Tomoko Kawaguchi, Akio Tanaka, Michihiro Hide
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundSweat aggravates atopic dermatitis (AD). In patients with AD, type-I hypersensitivity to sweat may be shown by histamine release from patients’ basophils in response to the semi-purified sweat antigen (QR), and the presence of specific im
Externí odkaz:
https://doaj.org/article/28a76fbf1653457ebdc158b37e577834
Autor:
Risa Otsuka, Akio Tanaka, Masakazu Takahashi, Ryo Saito, Kazumasa Iwamoto, Shunsuke Takahagi, Takanobu Kan, Satoshi Morioke, Michihiro Hide
Publikováno v:
Allergology International, Vol 70, Iss 3, Pp 376-378 (2021)
Externí odkaz:
https://doaj.org/article/a8129ce3f30f4dccabf59703c0b84a17
Autor:
Takanobu Kan, Takaaki Hiragun, Kaori Ishii, Makiko Hiragun, Yuhki Yanase, Akio Tanaka, Michihiro Hide
Publikováno v:
Allergology International, Vol 64, Iss 3, Pp 266-271 (2015)
Background: We previously identified MGL_1304 secreted by Malassezia globosa as a sweat antigen for patients with atopic dermatitis (AD) and cholinergic urticaria (ChU). However, purifying native MGL_1304 from human sweat or culture supernatant of M.
Externí odkaz:
https://doaj.org/article/fc171df184154af29b6249302c753df5
Autor:
Ikuyo Sada, Yosuke Harada, Tomona Hiyama, Mina Mizukami, Takanobu Kan, Mikio Kawai, Yoshiaki Kiuchi
Publikováno v:
Melanoma Research; Dec2023, Vol. 33 Issue 6, p539-546, 8p
Autor:
Masakazu Takahashi, Yukihiro Ohya, Ryo Saito, Akio Tanaka, Satoshi Morioke, Takanobu Kan, Michihiro Hide, Kazumasa Iwamoto, Naoki Shimojo, Maiko Tanaka, Shunsuke Takahagi
Publikováno v:
The Journal of Dermatology. 48:1602-1606
Atopic dermatitis (AD) mostly develops in early childhood and tends to resolve with age. However, its time course in severity before and after adolescence varies widely among patients. To investigate the course of disease severity from birth to 19 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b8204b6fe61bce03d69c7944ef263e
https://doi.org/10.1111/1346-8138.16085
https://doi.org/10.1111/1346-8138.16085
Autor:
Satoshi Morioke, Kazumasa Iwamoto, Risa Otsuka, Ryo Saito, Akio Tanaka, Takanobu Kan, Michihiro Hide, Shunsuke Takahagi, Masakazu Takahashi
Publikováno v:
Allergology International, Vol 70, Iss 3, Pp 376-378 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9f015db6c7eecd0046aa8429190f14c
https://doi.org/10.1016/j.alit.2020.11.009
https://doi.org/10.1016/j.alit.2020.11.009
Publikováno v:
The Journal of Dermatology. 47:907-910
Immune checkpoint inhibitors (ICI) have been administrated as a standard medication in many cases of malignant melanoma (MM). They may be effective even for MM in advanced stages. However, it is still challenging to reduce the burden of MM, which wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8f0ce1d698fe1da8cb7a1b0d137300
https://doi.org/10.1111/1346-8138.15408
https://doi.org/10.1111/1346-8138.15408